Przemysław J. Danek

Statistics

Publications

Citations

115

H-Index

Active since

2020

Affiliations

Maj Institute of Pharmacology(Current)

Polish Academy of Sciences

Przemysław J. Danek is an author at Maj Institute of Pharmacology specializing in cytochrome p450 enzyme activity, medicine, and cytochrome p450-mediated metabolism.

ORCID

Publications per year

2020–2021

Publications

In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug–drug interactions

Jacek Wójcikowski, Przemysław J. Danek, Agnieszka Basińska-Ziobroń et al. · Pharmacological Reports · 2020 · 46 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions

Przemysław J. Danek, Jacek Wójcikowski, Władysława A. Daniel · Pharmacological Reports · 2020 · 19 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Cytochrome P450 2D (CYP2D) enzyme dysfunction associated with aging and serotonin deficiency in the brain and liver of female Dark Agouti rats

Anna Haduch, Przemysław J. Danek, Wojciech Kuban et al. · Neurochemistry International · 2021 · 16 citations

Medicine, Neuroscience, Pharmacology +12

Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4

Przemysław J. Danek, Agnieszka Basińska-Ziobroń, Jacek Wójcikowski et al. · Pharmacological Reports · 2020 · 12 citations · Full text

Medicine, Pharmacology, Toxicology +17

Asenapine and iloperidone decrease the expression of major cytochrome P450 enzymes CYP1A2 and CYP3A4 in human hepatocytes. A significance for drug-drug interactions during combined therapy

Przemysław J. Danek, Jacek Wójcikowski, Władysława A. Daniel · Toxicology and Applied Pharmacology · 2020 · 11 citations

Medicine, Pharmacokinetics, Pharmacology +17

1–5 of 6